Friday, June 28, 2013 11:55:39 PM
All calculations are done in US dollars
-Revenue $168,800,000
-Gross profit $38,900,000
-Shares issued and OS after R/S 1,629,463 (IMO this will make up the 3.25% that current BOD of DMPD retains after reverse acquisition)
-96.75 x 1,629,463 / 3.25 = 48,507,860 (This is total shares issued and OS after reverse acquisition)
-With the gross profit and the shares issued and OS after reverse acquisition than the approximate EPS = .8
-Assumption: price/earnings ratio conservative estimate 20
The PPS after R/S could be as high as $16!!!
So the timing of the reverse acquisition and the reverse split are really what determines the immediate future for stock price.
Given the calculations above, it is realistic to say that the PPS could be as high as .085 before a R/S of 1:188. This is only if investors knew that the IRI$ reverse acquisition was for sure!
Have a nice weekend and as always this is all IMO
Recent NAHD News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/29/2023 04:42:08 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 04:48:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 05:33:51 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/28/2023 03:12:51 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 02:41:02 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/09/2023 08:15:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/04/2023 09:13:51 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/29/2023 03:24:39 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM